We are live on ! Find out more
199.70 USD
-4.93
2.41%
At close Updated Nov 11, 4:00 PM EST
Pre-market
After hours
199.70
0.00
0%
1 day
-2.41%
5 days
-1.82%
1 month
21.47%
3 months
20.61%
6 months
67.87%
Year to date
5.85%
1 year
22.2%
5 years
-27.43%
10 years
149.03%
 

About: Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Employees: 40,100

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 44.4%
Neutral 44.4%
Negative 11.1%
Neutral
Business Wire
6 days ago
ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site Communications
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the release of AI-directed video production capabilities within its FIRECREST site & patient communications platform. ICON's FIRECREST AI-directed video engine enables sponsors to automate the creation of high-quality, high-impact clinical trial videos. Unlike generic and unrestricted generative AI video tools, ICON's FIRECREST empowers sponsors by delivering consistent, scalabl.
ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site Communications
Neutral
Seeking Alpha
14 days ago
ICON Public Limited Company (ICLR) Q3 2026 Earnings Call Transcript
ICON Public Limited Company ( ICLR ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division David Windley - Jefferies LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Charles Rhyee - TD Cowen, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Kevin Caliendo - UBS Investment Bank, Research Division Luke Sergott - Barclays Bank PLC, Research Division Jack Meehan - Operon Research, LLC Sean Dodge - BMO Capital Markets Equity Research Jared Haase - William Blair & Company L.L.C.
ICON Public Limited Company (ICLR) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
14 days ago
What Icon (ICLR) Said on Its Q3 Earnings Call
Icon NASDAQ: ICLR reported third-quarter 2026 results that management said were in line with expectations, citing record net business wins, improving margins and continued investment in technology-enabled clinical development services.
What Icon (ICLR) Said on Its Q3 Earnings Call
Positive
Zacks Investment Research
14 days ago
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
Icon PLC (ICLR) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $3.31 per share a year ago.
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
Neutral
Seeking Alpha
15 days ago
Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exelixis rounded out our top contributors.
Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
Negative
Zacks Investment Research
22 days ago
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Neutral
Business Wire
1 month ago
ICON Schedules Third Quarter 2026 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON Schedules Third Quarter 2026 Earnings Conference Call.
ICON Schedules Third Quarter 2026 Earnings Conference Call
Positive
Zacks Investment Research
2 months ago
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Positive
Seeking Alpha
3 months ago
Oakmark Concentrated Strategy Q2 2026 Performance Review
The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
Oakmark Concentrated Strategy Q2 2026 Performance Review
Neutral
Zacks Investment Research
3 months ago
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Price charts implemented using Lightweight Charts™